Impact of radio(chemo)therapy on expression of immune checkpoint ligands PD-L1 and PD-L2 on murine and human melanoma cells

Riegel D, Bäumler M, Spiljar M, Rückert M, Frey B, Fietkau R, Derer A, Gaipl U (2017)

Publication Type: Conference contribution, Abstract of a poster

Publication year: 2017

Journal

Strahlentherapie und Onkologie Urban & Vogel

Publisher: SPRINGER HEIDELBERG

Book Volume: 193

Pages Range: S132-S132

Event location: ESTREL Congress & Messe Center Sonnenallee 225 Berlin, 12057

Authors with CRIS profile

Monika Neiswirth Medizinische Fakultät Michael Rückert Department of Radiation Oncology Benjamin Frey Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie Anja Derer Department of Radiation Oncology Udo Gaipl Medizinische Fakultät

Involved external institutions

Regensburg Center for Interventional Immunology DE Germany (DE)

How to cite

APA:

Riegel, D., Bäumler, M., Spiljar, M., Rückert, M., Frey, B., Fietkau, R.,... Gaipl, U. (2017, June). Impact of radio(chemo)therapy on expression of immune checkpoint ligands PD-L1 and PD-L2 on murine and human melanoma cells. Poster presentation at DEGRO - Deutsche Gesellschaft für Radioonkologie e.V., ESTREL Congress & Messe Center Sonnenallee 225 Berlin, 12057.

MLA:

Riegel, Dania, et al. "Impact of radio(chemo)therapy on expression of immune checkpoint ligands PD-L1 and PD-L2 on murine and human melanoma cells." Presented at DEGRO - Deutsche Gesellschaft für Radioonkologie e.V., ESTREL Congress & Messe Center Sonnenallee 225 Berlin, 12057 SPRINGER HEIDELBERG, 2017.

BibTeX: Download